Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

biotech

  • Home
  •  
  • biotech



  • Most Read
  • Latest Comments
  • Top biotech dealmaker appointed Chairman of Crowd Media
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Top biotech dealmaker appointed Chairman of Crowd Media
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Top biotech dealmaker appointed Chairman of Crowd Media
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Top biotech dealmaker appointed Chairman of Crowd Media
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Top biotech dealmaker appointed Chairman of Crowd Media
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • Harris Technology sees big opportunity for refurbished tech in 2025 with positive cash flow
    Harris Technology sees big opportunity for refurbished tech in 2025 with positive cash flow
    • News

  • Harris Technology continues growth with refurbished tech sales surpassing second $1M in just three months
    Harris Technology continues growth with refurbished tech sales surpassing second $1M in just three months
    • News

  • Top biotech dealmaker appointed Chairman of Crowd Media
    • News

    Top biotech dealmaker appointed Chairman of Crowd Media

    When one of Europe’s top executives has his previous business sold for $830 million and accepts a role to lead a microcap tech company, he’s clearly seen something behind the scenes to suggest it won’t be a microcap for much longer. That’s exactly the case with former Synlab executive Sytze Voulon who has been appointed

    Read More
    Public
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

    Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch

    “How much does it hurt, on a scale of 1-10?” Easily the most frustratingly vague of medical questions due to the huge difference in pain thresholds and perceptions. I don’t know about you, but I’m saving my 10 for childbirth.  Nonetheless, when the answer falls beneath an epidural-requiring 10, many of us reach for simple

    Read More
    Public
  • This $22 million company is changing the future of surgery
    • News

    This $22 million company is changing the future of surgery

    The first evidence of surgery, if you can call it that, dates back to the Neolithic and pre-Classical periods where skull trephining took place. The gruesome practice of cutting small holes in the head was thought to rid the body of spirits and was widely practised throughout Europe, Africa and South America. The Egyptians even

    Read More
    Public
  • Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement
    • News

    Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement

    4,440 US hospitals and health systems will soon have access to Avita Medical’s (ASX: AVH) proprietary RECELL System thanks to a purchasing agreement signed with Premier, a leading healthcare improvement company in the US.  Premier’s mission is to enable optimal patient care at reasonable cost within their alliance of 4,400 US hospitals and 225,000 other

    Read More
    Public
  • Pharmaxis reports progress in clinical trials despite COVID affecting industry
    • News

    Pharmaxis reports progress in clinical trials despite COVID affecting industry

    Things are well and truly on track for clinical stage pharmaceutical company Pharmaxis (ASX: PXS), a sentiment confirmed by CEO Gary Phillips in his shareholder address in their recent quarterly results. The Company has made significant progress in three clinical trial programs, with plenty on the horizon for their preclinical pipeline too.  Lead asset PXS-5505

    Read More
    Public
  • Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease
    • News

    Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease

    Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote sub-Antarctic Auckland Islands might not have been your first choice but that’s exactly where biotech company Living Cell Technologies (ASX: LCT) will obtain tissue for their clinical trials.  Specifically, Living Cell Technologies has secured a

    Read More
    Public
  • «
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.